Pyxis Tankers Announces Filing of Form 20-F for the Year Ended December 31, 2024
Maroussi, Greece – March 28, 2025 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), an international shipping company, announced today […]
Enact Releases 2024 Sustainability Report
RALEIGH, N.C., March 28, 2025 (GLOBE NEWSWIRE) — Enact Holdings, Inc. (Nasdaq: ACT) (Enact) today announced the release of its […]
Enlight Announces Filing of Form 20-F For The Year Ended December 31, 2024
TEL AVIV, Israel, March 28, 2025 (GLOBE NEWSWIRE) — Enlight Renewable Energy Ltd. (NASDAQ: ENLT, TASE: ENLT) today announced that […]
Castor Maritime Inc. Announces the Completion of the Sale of the M/V Magic Eclipse
LIMASSOL, Cyprus, March 28, 2025 (GLOBE NEWSWIRE) — Castor Maritime Inc. (NASDAQ: CTRM), (“Castor” or the “Company”), a diversified global […]
Kornit Digital Files Annual Report on Form 20-F for the Year Ended December 31, 2024
ROSH-HA`AYIN, Israel, March 28, 2025 (GLOBE NEWSWIRE) — Kornit Digital LTD. (NASDAQ: KRNT) (“Kornit Digital” or the “Company”), a global pioneer in sustainable, […]
Helport AI to Host First Half Fiscal Year 2025 Financial Results Conference Call on Monday, March 31, 2025 at 4:30 p.m. Eastern Time
SINGAPORE and SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) — Helport AI Limited (NASDAQ: HPAI) (“Helport AI” or the “Company”), […]
Live Ventures CEO Announces Purchase of 55,796 Shares of the Company’s Common Stock in the Open Market
LAS VEGAS, March 28, 2025 (GLOBE NEWSWIRE) — Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified […]
Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates
WALTHAM, Mass., March 28, 2025 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology […]
Meiwu Technology Company Limited Announces 1 for 20 Reverse Share Split
SHENZHEN, China, March 28, 2025 (GLOBE NEWSWIRE) — Meiwu Technology Company Limited (NASDAQ: WNW) (“WNW” or the “Company”), announced today […]
Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China
PROVIDENCE, R.I., March 28, 2025 (GLOBE NEWSWIRE) — Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company dedicated to advancing innovative […]
